# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093950
Filing Date
2024-08-08
Accepted
2024-08-08 16:10:27
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | gern-20240630.htm iXBRL | 10-Q | 2394507
2 | EX-31.1 | gern-ex31_1.htm | EX-31.1 | 15463
3 | EX-31.2 | gern-ex31_2.htm | EX-31.2 | 15492
4 | EX-32.1 | gern-ex32_1.htm | EX-32.1 | 8274
5 | EX-32.2 | gern-ex32_2.htm | EX-32.2 | 8148
| Complete submission text file | 0000950170-24-093950.txt |  | 8542916

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | gern-20240630.xsd | EX-101.SCH | 1113867
57 | EXTRACTED XBRL INSTANCE DOCUMENT | gern-20240630_htm.xml | XML | 1583058

Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 241188379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)